Nicole Vitullo - Net Worth and Insider Trading
Nicole Vitullo Net Worth
The estimated net worth of Nicole Vitullo is at least $40 Million dollars as of 2024-04-24. Nicole Vitullo is the 10% Owner of Zogenix Inc and owns about 825,323 shares of Zogenix Inc (ZGNX) stock worth over $22 Million. Nicole Vitullo is the Director of Achillion Pharmaceuticals Inc and owns about 2,391,407 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $16 Million. Nicole Vitullo is also the 10% Owner of Alimera Sciences Inc and owns about 279,297 shares of Alimera Sciences Inc (ALIM) stock worth over $997,090. Besides these, Nicole Vitullo also holds Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Esperion Therapeutics Inc (ESPR) , Marinus Pharmaceuticals Inc (MRNS) , Orexigen Therapeutics Inc (OREXQ) , Regado Biosciences Inc (RGDO) . Details can be seen in Nicole Vitullo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nicole Vitullo has not made any transactions after 2021-03-15 and currently still holds the listed stock(s).
Transaction Summary of Nicole Vitullo
Nicole Vitullo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nicole Vitullo owns 30 companies in total, including Esperion Therapeutics Inc (ESPR) , Achillion Pharmaceuticals Inc (ACHN) , and Marinus Pharmaceuticals Inc (MRNS) among others .
Click here to see the complete history of Nicole Vitullo’s form 4 insider trades.
Insider Ownership Summary of Nicole Vitullo
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ESPR | Esperion Therapeutics Inc | 2019-03-19 | director & 10 percent owner |
ACHN | Achillion Pharmaceuticals Inc | 2020-01-28 | director |
MRNS | Marinus Pharmaceuticals Inc | 2021-03-15 | director & 10 percent owner |
OBLN | Obalon Therapeutics Inc | 2019-08-06 | 10 percent owner |
ADYX | Adynxx Inc | 2019-05-03 | 10 percent owner |
BNGO | Bionano Genomics Inc | 2018-08-21 | 10 percent owner |
DRNA | Dicerna Pharmaceuticals Inc | 2017-12-18 | 10 percent owner |
OCRX | Ocera Therapeutics Inc | 2017-12-11 | 10 percent owner |
RGDO | Regado Biosciences Inc | 2016-11-01 | 10 percent owner |
CLCD | CoLucid Pharmaceuticals Inc | 2016-09-09 | 10 percent owner |
CPXX | Celator Pharmaceuticals Inc | 2016-07-12 | director |
EVOK | Evoke Pharma Inc | 2013-09-24 | 10 percent owner |
SNDX | Syndax Pharmaceuticals Inc | 2016-03-02 | 10 percent owner |
GKOS | Glaukos Corp | 2015-06-24 | 10 percent owner |
LIFE | aTyr Pharma Inc | 2015-05-06 | 10 percent owner |
EVFM | Evofem Biosciences Inc | 2014-11-19 | 10 percent owner |
ATRA | Atara Biotherapeutics Inc | 2014-10-15 | 10 percent owner |
VCYT | Veracyte Inc | 2013-10-29 | 10 percent owner |
OTIC | Otonomy Inc | 2014-08-12 | 10 percent owner |
ALDX | Aldeyra Therapeutics Inc | 2014-05-01 | 10 percent owner |
AKAOQ | Achaogen Inc | 2014-03-17 | 10 percent owner |
ALIM | Alimera Sciences Inc | 2011-06-02 | 10 percent owner |
TNDM | Tandem Diabetes Care Inc | 2013-11-13 | 10 percent owner |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 10 percent owner |
OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 10 percent owner |
ZGNX | Zogenix Inc | 2011-09-16 | 10 percent owner |
VNDA | Vanda Pharmaceuticals Inc | 2006-04-12 | 10 percent owner |
PRTK | Paratek Pharmaceuticals Inc | 2006-05-09 | 10 percent owner |
NUVA | NuVasive Inc | 2004-05-12 | 10 percent owner |
RSLS | Reshape Lifesciences Inc | 2016-10-05 | 10 percent owner |
Nicole Vitullo Latest Holdings Summary
Nicole Vitullo currently owns a total of 9 stocks. Among these stocks, Nicole Vitullo owns 825,323 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $22 Million and a weighting of 55.47%. Nicole Vitullo owns 2,391,407 shares of Achillion Pharmaceuticals Inc (ACHN) as of November 11, 2015, with a value of $16 Million and a weighting of 40.73%. Nicole Vitullo also owns 279,297 shares of Alimera Sciences Inc (ALIM) as of June 2, 2011, with a value of $997,090 and a weighting of 2.51%. The other 6 stocks Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Esperion Therapeutics Inc (ESPR) , Marinus Pharmaceuticals Inc (MRNS) , Orexigen Therapeutics Inc (OREXQ) , Regado Biosciences Inc (RGDO) have a combined weighting of 1.29% among all his current holdings.
Latest Holdings of Nicole Vitullo
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZGNX | Zogenix Inc | 2010-11-29 | 825,323 | 26.68 | 22,019,618 |
ACHN | Achillion Pharmaceuticals Inc | 2015-11-11 | 2,391,407 | 6.76 | 16,165,911 |
ALIM | Alimera Sciences Inc | 2011-06-02 | 279,297 | 3.57 | 997,090 |
OCRX | Ocera Therapeutics Inc | 2013-07-15 | 246,386 | 1.79 | 441,031 |
CLVSQ | Clovis Oncology Inc | 2011-11-21 | 3,041,950 | 0.02 | 45,629 |
ESPR | Esperion Therapeutics Inc | 2019-03-19 | 8,319 | 2.09 | 17,387 |
MRNS | Marinus Pharmaceuticals Inc | 2021-03-15 | 3,692 | 1.45 | 5,353 |
OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 301,806 | 0.01 | 1,600 |
RGDO | Regado Biosciences Inc | 2013-08-27 | 2,603,208 | 0.00 | 0 |
Holding Weightings of Nicole Vitullo
Nicole Vitullo Form 4 Trading Tracker
According to the SEC Form 4 filings, Nicole Vitullo has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 293,750 shares on November 29, 2010, which cost Nicole Vitullo around $9 Million.
According to the SEC Form 4 filings, Nicole Vitullo has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 550,000 shares on November 11, 2015, which brought Nicole Vitullo around $6 Million.
According to the SEC Form 4 filings, Nicole Vitullo has made a total of 0 transactions in Alimera Sciences Inc (ALIM) over the past 5 years. The most-recent trade in Alimera Sciences Inc is the sale of 461 shares on June 2, 2011, which brought Nicole Vitullo around $55,589.
More details on Nicole Vitullo's insider transactions can be found in the Insider Trading History of Nicole Vitullo table.Insider Trading History of Nicole Vitullo
- 1
Nicole Vitullo Trading Performance
GuruFocus tracks the stock performance after each of Nicole Vitullo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nicole Vitullo is 15.68%. GuruFocus also compares Nicole Vitullo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nicole Vitullo within 3 months outperforms 5 times out of 19 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nicole Vitullo's insider trading performs compared to the benchmark.
Performance of Nicole Vitullo
Average Return
-5.07%
Outperforming Transactions
32%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 14.92 | 15.68 | 22.11 | -5.07 | -16.01 | -7.3 |
Relative Return to S&P 500(%) | 11.38 | 10.65 | 14.06 | -17.55 | -27.54 | -18.79 |
Nicole Vitullo Ownership Network
Ownership Network List of Nicole Vitullo
Ownership Network Relation of Nicole Vitullo
Nicole Vitullo Owned Company Details
What does Esperion Therapeutics Inc do?
Who are the key executives at Esperion Therapeutics Inc?
Nicole Vitullo is the director & 10 percent owner of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .
Esperion Therapeutics Inc (ESPR) Insider Trades Summary
Over the past 18 months, Nicole Vitullo made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,644 shares made by Eric Warren , a net sale of 9,821 shares made by Joanne M. Foody , and a net purchase of 7,560 shares made by Sheldon L. Koenig .
In summary, during the past 3 months, insiders sold 0 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,542 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 22,069 shares.
Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Esperion Therapeutics Inc Insider Transactions
Nicole Vitullo Mailing Address
Above is the net worth, insider trading, and ownership report for Nicole Vitullo. You might contact Nicole Vitullo via mailing address: 3030 Science Park Road, San Diego Ca 92121.